Prostate–Specific Antigen Complexed to α1–Antichymotrypsin in the Early Detection of Prostate Cancer
暂无分享,去创建一个
F. España | A. Estellés | J. Aznar | P. Medina | J. Jiménez-Cruz | M. Martínez | M. Royo | C. D. Vera
[1] F. España,et al. Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: studies in serum and plasma samples. , 1998, Journal of Urology.
[2] W. J. Allard,et al. Novel immunoassay for the measurement of complexed prostate-specific antigen in serum. , 1998, Clinical chemistry.
[3] W. Catalona,et al. Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer. , 1998, The Journal of urology.
[4] V. Ravery,et al. Free/total prostate-specific antigen ratio--hope and controversies. , 1997, European urology.
[5] P. Schellhammer,et al. Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system. , 1997, Urology.
[6] S. Loening,et al. The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia , 1997, Cancer.
[7] F. España,et al. Reference ranges for the concentrations of total and complexed plasma prostate-specific antigen and their ratio in patients with benign prostate hyperplasia. , 1997, European urology.
[8] A W Partin,et al. Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age. , 1996, Urology.
[9] J. Griffin,et al. Quantitative immunoassay for complexes of prostate-specific antigen with alpha2-macroglobulin. , 1996, Clinical chemistry.
[10] F. España,et al. Prostate-specific antigen and its complexes with alpha 1-antichymotrypsin in the plasma of patients with prostatic disease. , 1996, European urology.
[11] F Schoonjans,et al. MedCalc: a new computer program for medical statistics. , 1995, Computer methods and programs in biomedicine.
[12] R. Gittes,et al. Prostate specific antigen-alpha 2-macroglobulin complexes in prostate cancer patient sera. , 1995, Biochemistry and molecular biology international.
[13] R. Kane,et al. Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age‐referenced PSA, PSA density, and PSA change , 1994, Cancer.
[14] W. Catalona,et al. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. , 1994, The Journal of urology.
[15] O. Nilsson,et al. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. , 1993, The Journal of urology.
[16] J. Gilabert,et al. Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen. , 1991, Thrombosis research.
[17] U. Stenman,et al. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. , 1991, Cancer research.
[18] R. Vessella,et al. The value of serum prostate specific antigen determinations before and after radical prostatectomy. , 1989, The Journal of urology.
[19] T. Stamey,et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. , 1988, The New England journal of medicine.